Why the study?
The study aimed to identify autonomic and gastric myoelectric biomarkers throughout the day to differentiate patients with gastroparesis, diabetics without gastroparesis, and healthy controls, while providing insight into etiology.
Observational (n=13)
No
At-home 24-hour non-invasive autonomic and gastric myoelectric monitoring can accurately differentiate between healthy controls, gastroparesis patients, and diabetics without gastroparesis.
Supports non-invasive gastroparesis differentiation; hypothesis-generating and requires prospective validation before practice change.
Objective The goal of this study was to identify autonomic and gastric myoelectric biomarkers from throughout the day that differentiate patients with gastroparesis, diabetics without gastroparesis, and healthy controls, while providing insight into etiology. Methods We collected 19 24-hour recordings of electrocardiogram (ECG) and electrogastrogram (EGG) data from healthy controls and patients with diabetic or idiopathic gastroparesis. We used physiologically and statistically rigorous models to extract autonomic and gastric myoelectric information from the ECG and EGG data respectively. From these, we constructed quantitative indices which differentiated the different groups and demonstrated their application in automatic classification paradigms and as quantitative summary scores. Results We identified several differentiators that separate healthy controls from gastroparetic patient groups, specifically around sleep and meals. We also demonstrated the downstream utility of these differentiators in automatic classification and quantitative scoring paradigms. Even with this small pilot dataset, automated classifiers achieved an accuracy of 79% separating autonomic phenotypes and 65% separating gastrointestinal phenotypes. We also achieved 89% accuracy separating controls from gastroparetic patients in general and 90% accuracy separating diabetics with and without gastroparesis. These differentiators also suggested varying etiologies for different phenotypes. Conclusion The differentiators we identified were able to successfully distinguish between several autonomic and gastrointestinal (GI) phenotypes using data collected while at-home with non-invasive sensors. Significance Autonomic and gastric myoelectric differentiators, obtained using at-home recording of fully non-invasive signals, can be the first step towards dynamic quantitative markers to track severity, disease progression, and treatment response for combined autonomic and GI phenotypes.
No takes yet. Share an insight, caveat, or question.
Subramanian et al. (2022) conducted an observational in Gastroparesis (n=13). Autonomic and gastric myoelectric monitoring vs. Healthy controls was evaluated on Accuracy of automated classifiers separating controls from gastroparetic patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: